Cargando…
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
In recent years, scientists have advocated the use of targeted therapies in the form of drugs that modulate genes and proteins that are directly associated with cancer progression and metastasis. Malignant melanoma is a dreadful cancer type that has been associated with the rapid dissemination of pr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586801/ https://www.ncbi.nlm.nih.gov/pubmed/26393652 http://dx.doi.org/10.3390/cancers7030868 |